Advertisement
Advertisement
Powered by eeNation.com
Click2Cancer.com  > Treatments of Cancer > Bone Marrow Transplantation
Top Cancer Hospitals
Types of Cancer
Top cancer hospitals take your money & get your hopes up! Without cancer, no hospitals!
Mr. John Santopadre (in picture) - One of the top entrepreneurs in New Orleans!  Started in the show business and succeeded as one of the top businessmen in New Orleans! 

Ms. Penny Killeen - A woman that will never be forgotten in the eyes of the Maggio family.  Thank you Penny for helping us with everything.  Now that you've joined your son, you can rest now!
Causes of Cancer
Other Treatments
Hematopoietic stem cell transplantation (HSCT) is the transplantation of blood stem cells derived from the bone marrow (that is, bone marrow transplantation) or blood. Stem cell transplantation is a medical procedure in the fields of hematology and oncology, most often performed for people with diseases of the blood, bone marrow, or certain types of cancer.

Stem cell transplantation was pioneered using bone-marrow-derived stem cells by a team at the Fred Hutchinson Cancer Research Center from the 1950s through the 1970s led by E. Donnall Thomas, whose work was later recognized with a Nobel Prize in Physiology and Medicine. Thomas' work showed that bone marrow cells infused intravenously could repopulate the bone marrow and produce new blood cells. His work also reduced the likelihood of developing a life-threatening complication called graft-versus-host disease.

The first physician to perform a successful human bone marrow transplant was Robert A. Good.

With the availability of the stem cell growth factors GM-CSF and G-CSF, most hematopoietic stem cell transplantation procedures are now performed using stem cells collected from the peripheral blood, rather than from the bone marrow. Collecting peripheral blood stem cells provides a bigger graft, does not require that the donor be subjected to general anesthesia to collect the graft, results in a shorter time to engraftment, and may provide for a lower long-term relapse rate.

Hematopoietic stem cell transplantation remains a risky procedure with many possible complications; it has traditionally been reserved for patients with life-threatening diseases. While occasionally used experimentally in nonmalignant and nonhematologic indications such as severe disabling auto-immune disease and cardiovascular disease, the risk of fatal complications appears too high to gain wider acceptance.

..........................More information on Bone Marrow Transplantation >
Click Here